Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.04 is 70% above its 5-year average of -0.13, near the high end of its 5-year range (-0.30–-0.03).
57.24% above its 12-month average of -0.09.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.01.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:12:47.897Z. Historical observations retain their original dates. Historical series through 2020-11-12.
EARNINGS PER SHARE (EPS)
-0.04
EARNINGS PER SHARE (EPS) AVG TTM
-0.09
EARNINGS PER SHARE (EPS) AVG 3Y
-0.17
EARNINGS PER SHARE (EPS) AVG 5Y
-0.13
EARNINGS PER SHARE (EPS) AVG 10Y
-0.07
EARNINGS PER SHARE (EPS) AVG 15Y
-0.02
EARNINGS PER SHARE (EPS) AVG 20Y
0.00
CURRENT VS TTM AVG
+57.24%
CURRENT VS 3Y AVG
+76.37%
CURRENT VS 5Y AVG
+70.22%
CURRENT VS 10Y AVG
+39.96%
CURRENT VS 15Y AVG
-80.23%
CURRENT VS 20Y AVG
-3646.80%
KORU Medical Systems, Inc.
Market Cap
$136.88M
Earnings Per Share (EPS)
-0.04
TTM Avg
-0.09
3Y Avg
-0.17
5Y Avg
-0.13
Market Cap
$136.52M
Earnings Per Share (EPS)
-3.85
TTM Avg
-4.48
3Y Avg
-4.48
5Y Avg
-4.48
Market Cap
$136.15M
Earnings Per Share (EPS)
-0.18
TTM Avg
-0.17
3Y Avg
-0.17
5Y Avg
-0.09
Market Cap
$134.69M
Earnings Per Share (EPS)
-0.51
TTM Avg
-0.38
3Y Avg
-0.76
5Y Avg
-1.59
Market Cap
$139.73M
Earnings Per Share (EPS)
2.68
TTM Avg
-1.38
3Y Avg
-6.44
5Y Avg
-7.90
Market Cap
$133.22M
Earnings Per Share (EPS)
-1.41
TTM Avg
-1.30
3Y Avg
-2.00
5Y Avg
-1.82
Market Cap
$140.25M
Earnings Per Share (EPS)
-1.11
TTM Avg
-1.59
3Y Avg
-2.87
5Y Avg
-3.93
Market Cap
$133.17M
Earnings Per Share (EPS)
0.45
TTM Avg
-0.23
3Y Avg
-0.84
5Y Avg
-0.86
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | $136.88M | -0.04 | -0.09 | -0.17 | -0.13 |
| Atrium Therapeutics, Inc. (RNA)vs › | $136.52M | -3.85 | -4.48 | -4.48 | -4.48 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $136.15M | -0.18 | -0.17 | -0.17 | -0.09 |
| Freenome, Inc. (FRNM)vs › | $135.02M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $134.69M | -0.51 | -0.38 | -0.76 | -1.59 |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 2.68 | -1.38 | -6.44 | -7.90 |
| Pyxis Oncology, Inc. (PYXS)vs › | $133.22M | -1.41 | -1.30 | -2.00 | -1.82 |
| Alpha Cognition Inc (ACOG)vs › | $140.25M | -1.11 | -1.59 | -2.87 | -3.93 |
| Organigram Global Inc. (OGI)vs › | $133.17M | 0.45 | -0.23 | -0.84 | -0.86 |
| Health Catalyst, Inc. (HCAT)vs › | $131.53M | -3.68 | -1.85 | -2.09 | -2.42 |
Trailing EPS (TTM)
$-0.04
Forward EPS (Est.)
$-0.04
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.06 |
| 2024-12-31 | -0.13 |
| 2023-12-31 | -0.30 |
| 2022-12-31 | -0.19 |
| 2021-12-31 | -0.10 |
| 2020-12-31 | -0.03 |
| 2019-12-31 | 0.01 |
| 2018-12-31 | 0.02 |
| 2017-12-31 | 0.03 |
| 2017-02-28 | -0.01 |
| 2016-02-29 | 0.02 |
| 2015-02-28 | 0.02 |
| 2014-02-28 | 0.02 |
| 2013-02-28 | 0.02 |
| 2012-02-29 | 0.02 |
| 2011-02-28 | 0.02 |
| 2010-02-28 | 0.02 |
| 2009-02-28 | 0.03 |
| 2008-02-29 | 0.00 |
| 2007-02-28 | -0.01 |
| 2006-02-28 | -0.01 |
| 2005-02-28 | -0.02 |
| 2004-02-29 | -0.01 |
| 2003-02-28 | -0.01 |
| 2002-02-28 | -0.02 |
| 2001-02-28 | 0.00 |
| 2000-02-29 | 0.01 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T16:12:47.897Z. Historical observations retain their original dates. Historical series through 2020-03-04.
